These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10930894

  • 1. Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy.
    Cuffari C, Hunt S, Bayless TM.
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1009-14. PubMed ID: 10930894
    [Abstract] [Full Text] [Related]

  • 2. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease.
    Cuffari C, Hunt S, Bayless T.
    Gut; 2001 May; 48(5):642-6. PubMed ID: 11302961
    [Abstract] [Full Text] [Related]

  • 3. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
    Thomas CW, Lowry PW, Franklin CL, Weaver AL, Myhre GM, Mays DC, Tremaine WJ, Lipsky JJ, Sandborn WJ.
    Inflamm Bowel Dis; 2003 Jul; 9(4):237-45. PubMed ID: 12902847
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.
    Belaiche J, Desager JP, Horsmans Y, Louis E.
    Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242
    [Abstract] [Full Text] [Related]

  • 5. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
    Dubinsky MC.
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):731-43. PubMed ID: 15354273
    [Abstract] [Full Text] [Related]

  • 6. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM.
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [Abstract] [Full Text] [Related]

  • 7. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E, Macdonald JK, Sutherland LR.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD000545. PubMed ID: 19821270
    [Abstract] [Full Text] [Related]

  • 8. Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis.
    Nguyen TM, Daubard M, Le Gall C, Larger M, Lachaux A, Boulieu R.
    Ther Drug Monit; 2010 Aug 07; 32(4):433-7. PubMed ID: 20479703
    [Abstract] [Full Text] [Related]

  • 9. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
    Angelberger S, Schaeffeler E, Teml A, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR, Schwab M, Reinisch W.
    Inflamm Bowel Dis; 2013 Mar 07; 19(3):590-8. PubMed ID: 23388543
    [Abstract] [Full Text] [Related]

  • 10. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease.
    Lowry PW, Franklin CL, Weaver AL, Pike MG, Mays DC, Tremaine WJ, Lipsky JJ, Sandborn WJ.
    Gut; 2001 Nov 07; 49(5):665-70. PubMed ID: 11600469
    [Abstract] [Full Text] [Related]

  • 11. Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease.
    Achkar JP, Stevens T, Easley K, Brzezinski A, Seidner D, Lashner B.
    Inflamm Bowel Dis; 2004 Jul 07; 10(4):339-45. PubMed ID: 15475740
    [Abstract] [Full Text] [Related]

  • 12. 6-thioguanine--efficacy and safety in chronic active Crohn's disease.
    Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF.
    Aliment Pharmacol Ther; 2003 Feb 15; 17(4):503-8. PubMed ID: 12622758
    [Abstract] [Full Text] [Related]

  • 13. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.
    Cuffari C, Théorêt Y, Latour S, Seidman G.
    Gut; 1996 Sep 15; 39(3):401-6. PubMed ID: 8949645
    [Abstract] [Full Text] [Related]

  • 14. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S, Wilson-Rich N, Bousvaros A, Zholudev A, Maurer R, Banks P, Makrauer F, Reddy S, Burakoff R, Friedman S.
    Inflamm Bowel Dis; 2006 Apr 15; 12(4):251-7. PubMed ID: 16633046
    [Abstract] [Full Text] [Related]

  • 15. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.
    Boulton-Jones JR, Pritchard K, Mahmoud AA.
    Aliment Pharmacol Ther; 2000 Dec 15; 14(12):1561-5. PubMed ID: 11121903
    [Abstract] [Full Text] [Related]

  • 16. Optimizing treatment with thioguanine derivatives in inflammatory bowel disease.
    Louis E, Belaiche J.
    Best Pract Res Clin Gastroenterol; 2003 Feb 15; 17(1):37-46. PubMed ID: 12617881
    [Abstract] [Full Text] [Related]

  • 17. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM, Ng JF, Dowling D.
    Intern Med J; 2016 Apr 15; 46(4):465-9. PubMed ID: 26425841
    [Abstract] [Full Text] [Related]

  • 18. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
    Bonaz B, Boitard J, Marteau P, Lémann M, Coffin B, Flourié B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF, Getaid.
    Aliment Pharmacol Ther; 2003 Aug 15; 18(4):401-8. PubMed ID: 12940925
    [Abstract] [Full Text] [Related]

  • 19. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD000067. PubMed ID: 19160175
    [Abstract] [Full Text] [Related]

  • 20. Exploring associations of 6-thioguanine nucleotide levels and other predictive factors with therapeutic response to azathioprine in pediatric patients with IBD using multilevel analysis.
    Nguyen TV, Vu DH, Nguyen TM, Lachaux A, Boulieu R.
    Inflamm Bowel Dis; 2013 Oct 21; 19(11):2404-10. PubMed ID: 24013359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.